PA
ARLO icon

PharVision Advisers’s Arlo Technologies ARLO Stock Holding History

PharVision Advisers’s Portfolio ARLO Stock Details ARLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,831
Closed -$389K – 133
2025
Q4 		$389K Buy
27,831
+10,794
+63% +$170K 0.2% 136
2025
Q3 		$289K Buy
+17,037
New +$290K 0.16% 246

Other funds holding ARLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PharVision Advisers's ARLO Position: Q1 2026 in Review

PharVision Advisers sold out of Arlo Technologies (ARLO) in Q1 2026, closing a stake of 27,831 shares — an estimated $389K sold.

PharVision Advisers first reported a position in ARLO in Q3 2025 and held it in 2 quarters. The position peaked at $389K in Q4 2025. 276 funds tracked by Wall St. Rank hold ARLO as of Q1 2026.

  • PharVision Advisers reported no remaining Arlo Technologies position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 27,831 Arlo Technologies shares in Q1 2026, an estimated $389K.
  • PharVision Advisers first reported a position in Arlo Technologies in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Arlo Technologies position peaked at $389K in Q4 2025.
  • 276 funds tracked by Wall St. Rank held Arlo Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.